tirzepatide and vision changes GLP-1 drugs loss: How significant are the risks? Researchers Find Small Increased Risk

PlexusDx uses genetic insights to help match patients with the tirzepatide regimen most likely to succeedwhether that's the compounded injection version ($289 monthly) or the oral formulation ($349 monthly)

doi: 10.1016/j.freeradbiomed.2018.01.028 26 KirtoniaASethiGGargM

If youre on a potassium-sparing diuretic or an ACE inhibitor, dont add supplements without your prescribers input

Your cancer treatment efficacy remains unchanged

The SURMOUNT-5 trial, published in The New England Journal of Medicine in May 2025, is the first large randomized study to compare tirzepatide and semaglutide directly in adults with obesity

Meanwhile, Novo Nordisk faces headwinds